PHILADELPHIA, PA, May 13, 2025 – Exegenesis Bio, a global gene therapy company developing innovative genetic medicines for eye, CNS and liver-directed diseases is pleased to announce that two oral presentations and three posters will be presented at the 28th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT), May 13-17, 2025 in New Orleans, LA. Read full press release